The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Clinical Application of C-Reactive Protein for Cardiovascular Disease Detection and Prevention
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“concentrations greater than 3.0 mg/L are considered reliably predictive of cardiovascular disease risk (See Ridker, 2003 for review).”
From Developmental psychoneuroendocrine and psychoneuroimmune pathways from childhood adversity to disease (2017) · cites this paper as Ridker, 2003
In the citing paper
“Likewise, depression is often associated with other conditions where an increased inflammatory state has been documented, such as in cardiovascular diseases, obesity, smoking status, and specific nutritional deficits [24,25,26].”
From C-Reactive protein as a biomarker for major depressive disorder? (2022) · cites this paper as [24]
Citations
Cites
Ridker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850
Self-citationInflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Self-citationC-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Self-citationThe Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina
Liuzzo, G., Biasucci, L. M., Gallimore, J. R., Grillo, R. L., Rebuzzi, A. G., Pepys, M. B., & Maseri, A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199408183310701 · Cited by 2,354
Ridker, P. M., Buring, J. E., Cook, N. R., & Rifai, N. (2003) · Circulation · doi:10.1161/01.cir.0000055014.62083.05 · Cited by 2,292
Self-citationKöenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,952
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692
Effect of Statin Therapy on C-Reactive Protein Levels
Albert, M. A., Danielson, E., Rifai, N., Ridker, P. M., & for the PRINCE Investigators (2001) · JAMA · doi:10.1001/jama.286.1.64 · Cited by 1,644
Self-citationRidker, P. M., Rifai, N., Clearfield, M., Downs, J. R., Weis, S. E., Miles, J. S., & Gotto, A. M. (2001) · New England Journal of Medicine · doi:10.1056/nejm200106283442601 · Cited by 1,557
Self-citation
Cited by
Sorted by citations
Items 201–300 of 1,001
Popa, C. D., van den Hoogen, F. H. J., Radstake, T. R. D. J., Netea, M. G., Eijsbouts, A. M. M., den Heijer, M., van der Meer, J. W. M., van Riel, P. L. C. M., Stalenhoef, A. F. H., & Barrera, P. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.066191 · Cited by 154
Patel, R. S., Ghasemzadeh, N., Eapen, D. J., Sher, S., Arshad, S., Ko, Y., Veledar, E., Samady, H., Zafari, A. M., Sperling, L. S., et al. (2015) · Circulation · doi:10.1161/circulationaha.115.019790 · Cited by 154
Fatigue, Inflammation, and ω-3 and ω-6 Fatty Acid Intake Among Breast Cancer Survivors
Alfano, C. M., Imayama, I., Neuhouser, M. L., Kiecolt‐Glaser, J. K., Smith, A. W., Meeske, K., McTiernan, A., Bernstein, L., Baumgartner, K. B., Ulrich, C. M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.4109 · Cited by 153
The use of high-sensitivity assays for C-reactive protein in clinical practice
Musunuru, K., Kral, B. G., Blumenthal, R. S., Fuster, V., Campbell, C. Y., Gluckman, T. J., Lange, R. A., Topol, E. J., Willerson, J. T., Desai, M. Y., et al. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1322 · Cited by 160
Therapeutic Implications of Brain–Immune Interactions: Treatment in Translation
Miller, A. H., Haroon, E., & Felger, J. C. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.167 · Cited by 152
Elkhawad, M., Rudd, J. H. F., Sarov‐Blat, L., Cai, G., Wells, R., Davies, C., Collier, D., Marber, M. S., Choudhury, R. P., Fayad, Z. A., et al. (2012) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2012.02.016 · Cited by 152
Wachtel-Galor, S., Tomlinson, B., & Benzie, I. F. F. (2004) · British Journal Of Nutrition · doi:10.1079/bjn20041039 · Cited by 154
März, W., Scharnagl, H., Winkler, K., Tiran, A., Nauck, M., Boehm, B., & Winkelmann, B. (2004) · Circulation · doi:10.1161/01.cir.0000146898.06923.80 · Cited by 143
Steiropoulos, P., Tsara, V., Nena, E., Fitili, C., Kataropoulou, M., Froudarakis, Μ. E., Christaki, P. I., & Bouros, D. E. (2007) · CHEST Journal · doi:10.1378/chest.07-0074 · Cited by 150
Sibal, L., Aldibbiat, A. M., Agarwal, S., Mitchell, G., Oates, C. P., Razvi, S., Weaver, J. U., Shaw, J. A. M., & Home, P. (2009) · Diabetologia · doi:10.1007/s00125-009-1401-0 · Cited by 151
High sensitivity C-reactive protein (hsCRP) & cardiovascular disease: An Indian perspective
Pais, P. S., Kamath, D. Y., Xavier, D., & Sigamani, A. (2015) · The Indian Journal of Medical Research · doi:10.4103/0971-5916.166582 · Cited by 164
Lin, L., Kuo, H., Hwang, J., Lai, L., Chiang, F., Tseng, C.-D., & Lin, J.-L. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.021 · Cited by 149
Roles of IL-6-gp130 Signaling in Vascular Inflammation
Hou, T., Tieu, B. C., Ray, S., Recinos, A., Cui, R., Tilton, R. G., & Brasier, A. R. (2008) · Current Cardiology Reviews · doi:10.2174/157340308785160570 · Cited by 149
Huang, H., Chen, G., Liao, D., Zhu, Y., & Xue, X. (2016) · Scientific Reports · doi:10.1038/srep23625 · Cited by 157
Sliding-strip microfluidic device enables ELISA on paper
Verma, M. S., Tsaloglou, M., Sisley, T. A., Christodouleas, D. C., Chen, A. C., Milette, J., & Whitesides, G. M. (2017) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2017.07.034 · Cited by 152
Nikkheslat, N., Zunszain, P. A., Horowitz, M. A., Barbosa, I. G., Parker, J. A., Myint, A.-M., Schwarz, M. J., Tylee, A. T., Carvalho, L. A., & Pariante, C. M. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.02.002 · Cited by 147
Chronic PM2.5 exposure and inflammation: Determining sensitive subgroups in mid-life women
Ostro, B. D., Malig, B. J., Broadwin, R., Basu, R., Gold, E. B., Bromberger, J. T., Derby, C. A., Feinstein, S. B., Greendale, G. A., Jackson, E. A., et al. (2014) · Environmental Research · doi:10.1016/j.envres.2014.03.042 · Cited by 150
Atherosclerotic Plaque Stability—What Determines the Fate of a Plaque?
Halvorsen, B. L., Otterdal, K., Dahl, T. B., Skjelland, M., Gullestad, L. L., Øie, E., & Aukrust, P. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.09.001 · Cited by 146
Braith, R. W., Conti, C. R., Nichols, W. W., Choi, C., Khuddus, M. A., Beck, D. T., & Casey, D. P. (2010) · Circulation · doi:10.1161/circulationaha.109.923482 · Cited by 146
Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status
Devaraj, S., Rosenson, R. S., & Jialal, I. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.008 · Cited by 146
Nutritional mechanisms that influence cardiovascular disease
Caterina, R. D., Zampolli, A., Turco, S. D., Madonna, R., & Massaro, M. (2006) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.421s · Cited by 145
Marinac, C. R., Sears, D. D., Natarajan, L., Gallo, L. C., Breen, C. I., & Patterson, R. E. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136240 · Cited by 144
Metabolic syndrome, inflammation and atherosclerosis
Paoletti, R., Bolego, C., Poli, A., & Cignarella, A. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.2.145 · Cited by 147
Methods for Evaluating Endothelial Function in Humans
Barac, A., Campia, U., & Panza, J. A. (2007) · Hypertension · doi:10.1161/01.hyp.0000259601.38807.a6 · Cited by 145
Insulin Resistance and inflammation—A Further Systemic Complication of COPD
Bolton, C. E., Evans, M., Ionescu, A.-S., Edwards, S., Morris, R. H., Dunseath, G. J., Luzio, S. D., Owens, D. R., & Shale, D. J. (2007) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412550701341053 · Cited by 141
Thayer, J. F., & Fischer, J. E. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02023.x · Cited by 146
Metabolic Syndrome: Definition and Therapeutic Implications
Prasad, H., Ryan, D. A., Celzo, M. F., & Stapleton, D. D. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.01.2514 · Cited by 142
Rizvi, A. A. (2009) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181a4158c · Cited by 138
Kelley, D. S., Siegel, D., Fedor, D. M., Adkins, Y. C., & Mackey, B. E. (2009) · Journal of Nutrition · doi:10.3945/jn.108.100354 · Cited by 144
Ohsawa, M., Okayama, A., Nakamura, M., Onoda, T., Kato, K., Itai, K., Yoshida, Y., Ogawa, A., Kawamura, K., & Hiramori, K. (2005) · Preventive Medicine · doi:10.1016/j.ypmed.2005.02.002 · Cited by 140
C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling
Singh, U. S., Devaraj, S., Vasquez-Vivar, J. M., & Jialal, I. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.08.015 · Cited by 141
Kolek, M. J., Carlquist, J. F., Muhlestein, J. B., Whiting, B. M., Horne, B. D., Bair, T. L., & Anderson, J. L. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.05.049 · Cited by 137
Effects of Systemic Inflammation on Endothelium-Dependent Vasodilation
Huang, A. L., & Vita, J. A. (2005) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2005.10.002 · Cited by 137
Kelley, G. A., & Kelley, K. S. (2006) · Metabolism · doi:10.1016/j.metabol.2006.06.021 · Cited by 134
Phillips, K. R. B., Luk, A. C., Soor, G. S., Abraham, J. R., Leong, S. W., & BUTANY, J. W. (2009) · American Journal of Cardiovascular Drugs · doi:10.1007/bf03256574 · Cited by 163
Jensen, M. T., Marott, J. L., Allin, K. H., Nordestgaard, B. G., & Jensen, G. B. (2011) · European Journal of Preventive Cardiology · doi:10.1177/1741826710394274 · Cited by 135
Amezcua-Castillo, E., González‐Pacheco, H., Martín, A. S.-S., Méndez-Ocampo, P., Gutiérrez-Moctezuma, I., Massó, F., Sierra‐Lara, D., Springall, R., Rodrı́guez, E., Arias‐Mendoza, A., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11092444 · Cited by 152
Platelet activation and inflammatory response in patients with non-dipper hypertension
Kaya, M. G., Yarlıoğlueş, M., Günebakmaz, Ö., Güntürk, E. E., İnanç, T., Doğan, A., Kalay, N., & Topsakal, R. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.09.010 · Cited by 133
Brudey, C., Park, J., Wiaderkiewicz, J., Kobayashi, I., Mellman, T. A., & Marvar, P. J. (2015) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00343.2014 · Cited by 137
Wu, B., Jiang, R., Wang, Q., Huang, J. L., Yang, X., Wang, K., Li, W., Chen, N., & Li, Q. (2016) · Chemical Communications · doi:10.1039/c5cc10486f · Cited by 132
Inverse Association between Pulmonary Function and C-Reactive Protein in Apparently Healthy Subjects
Aronson, D., Roterman, I., Yigla, M., Kerner, A., Avizohar, O., Sella, R., Bartha, P., Levy, Y., & Markiewicz, W. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-243oc · Cited by 132
Ferramosca, E., Burke, S. K., Chasan-Taber, S., Ratti, C., Chertow, G. M., & Raggi, P. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.07.023 · Cited by 132
CRP and the risk of atherosclerotic events
Calabrò, P., Golia, E., & Yeh, E. T. H. (2009) · Seminars in Immunopathology · doi:10.1007/s00281-009-0149-4 · Cited by 134
Matsui, I., Hamano, T., Mikami, S., Fujii, N., Takabatake, Y., Nagasawa, Y., Kawada, N., Ito, T., Rakugi, H., Imai, E., et al. (2009) · Kidney International · doi:10.1038/ki.2008.700 · Cited by 130
Liu, Q., Gu, X., Deng, F., Mu, L., Baccarelli, A., Guo, X., & Wu, S. (2019) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2019.05.005 · Cited by 129
Stehouwer, C. D. A. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh015 · Cited by 128
Polycystic ovary syndrome and impact on health
Allahbadia, G. N., & Merchant, R. (2010) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2010.10.002 · Cited by 127
Sung, K., Ryan, M. C., & Wilson, A. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.07.024 · Cited by 126
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes
Dzau, V. J., Antman, E. M., Black, H. R., Hayes, D. L., Manson, J. E., Plutzky, J., Popma, J. J., & Stevenson, W. G. (2006) · Circulation · doi:10.1161/circulationaha.106.655761 · Cited by 130
Aiding and Abetting Anhedonia: Impact of Inflammation on the Brain and Pharmacological Implications
Lucido, M. J., Bekhbat, M., Goldsmith, D. R., Treadway, M. T., Haroon, E., Felger, J. C., & Miller, A. H. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000043 · Cited by 133
Cardiovascular risk in chronic kidney disease
Anavekar, N. S., & Pfeffer, M. A. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.09203.x · Cited by 125
Effect of particulate matter air pollution on C-reactive protein: a review of epidemiologic studies
Li, Y., Rittenhouse‐Olson, K., Scheider, W. L., & Mu, L. (2012) · Reviews on Environmental Health · doi:10.1515/reveh-2012-0012 · Cited by 124
Osimo, E. F., Cardinal, R. N., Jones, P. B., & Khandaker, G. M. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.02.031 · Cited by 124
Bemelmans, W. J. E., Lefrandt, J. D., Feskens, E. J. M., Haelst, P. L. V., Broer, J., Meyboom-de Jong, B., May, J. F., Tervaert, J. W. C., & Smit, A. J. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601938 · Cited by 123
Pneumonia as a cardiovascular disease
Restrepo, M. I., & Reyes, L. F. (2018) · Respirology · doi:10.1111/resp.13233 · Cited by 122
Landberg, R., Sun, Q., Rimm, E. B., Cassidy, A., Scalbert, A., Mantzoros, C. S., Hu, F. B., & van Dam, R. M. (2011) · The Journal of Nutrition · doi:10.3945/jn.110.133843 · Cited by 121
Effects of Anti‐TNF‐α Treatment on Lipid Profile in Patients with Active Rheumatoid Arthritis
SERIOLO, B., Paolino, S., Sulli, A., FASCIOLO, D., & Cutolo, M. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1351.039 · Cited by 121
Alkerwi, A., Baydarlioglu, B., Sauvageot, N., Stranges, S., Lemmens, P. H. H. M., Shivappa, N., & Hébert, J. R. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.08.013 · Cited by 123
Asbaghi, O., Sadeghian, M., Nazarian, B., Sarreshtedari, M., Mozaffari–Khosravi, H., Maleki, V., Alizadeh, M., Shokri, A., & Sadeghi, O. (2020) · Scientific Reports · doi:10.1038/s41598-020-73741-6 · Cited by 127
Nutritional genomics in practice: Where do we begin?
DeBusk, R. M., Fogarty, C. P., Ordovás, J. M., & Kornman, K. S. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2005.01.002 · Cited by 119
C‐Reactive Protein Levels in Patients With Aggressive Periodontitis
Salzberg, T. N., Overstreet, B. T., Rogers, J. D., Califano, J. V., Best, A. M., & Schenkein, H. A. (2006) · Journal of Periodontology · doi:10.1902/jop.2006.050165 · Cited by 119
C-reactive protein and atherothrombosis—Beyond a biomarker: an actual partaker of lesion formation
Verma, S., & Yeh, E. T. H. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00170.2003 · Cited by 119
Inflammation and reactivation of latent herpesviruses in older adults
Bennett, J. M., Glaser, R., Malarkey, W. B., Beversdorf, D. Q., Peng, J., & Kiecolt-Glaser, J. K. (2012) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.11.007 · Cited by 118
Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options.
Phillips, K. R. B., Luk, A. C., Soor, G. S., Abraham, J. R., Leong, S. W., & BUTANY, J. W. (2009) · PubMed · doi:10.2165/00129784-200909030-00005 · Cited by 118
Inflammation and Vascular Calcification
Moe, S. M., & Chen, N. X. (2004) · Blood Purification · doi:10.1159/000082013 · Cited by 118
Anti‐inflammatory Effects of α‐Tocopherol
Singh, U. S., & Jialal, I. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1331.019 · Cited by 119
Moody, D. L. B., Brown, C., Matthews, K. A., & Bromberger, J. T. (2014) · Journal of Social Issues · doi:10.1111/josi.12061 · Cited by 123
Cardiovascular Risk in Women With PCOS
Scicchitano, P., Dentamaro, I., Carbonara, R., Bulzis, G., Dachille, A., Caputo, P., Riccardi, R., Locorotondo, M., Mandurino, C., & Ciccone, M. M. (2012) · Intern J Endocrinol Metab · doi:10.5812/ijem.4020 · Cited by 117
Bekhbat, M., Li, Z., Mehta, N. D., Treadway, M. T., Lucido, M. J., Woolwine, B. J., Haroon, E., Miller, A. H., & Felger, J. C. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01715-3 · Cited by 125
IL-6 and Cardiovascular Risk: A Narrative Review
Mehta, N. N., deGoma, E. M., & Shapiro, M. D. (2024) · Current Atherosclerosis Reports · doi:10.1007/s11883-024-01259-7 · Cited by 140
Stalenhoef, A. F. H., Ballantyne, C. M., Sarti, C., Murín, J., Tonstad, S., Rose, H., & Wilpshaar, W. (2005) · European Heart Journal · doi:10.1093/eurheartj/ehi482 · Cited by 116
Association between butyrylcholinesterase activity and low-grade systemic inflammation
Lampón, N., Hermida-Cadahía, E. F., Riveiro, A., & Tutor, J. C. (2012) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30932-9 · Cited by 116
Kwon, K. A., Kim, S. H., Oh, S. Y., Lee, S., Han, J., Kim, K. H., Goh, R.-Y., Choi, H. J., Park, K., Roh, M. S., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-203 · Cited by 116
Schwedler, S. B., Amann, K., Wernicke, K., Krebs, A., Nauck, M. A., Wanner, C., Potempa, L. A., & Galle, J. (2005) · Circulation · doi:10.1161/circulationaha.105.556530 · Cited by 121
Thanabalasingham, G., Shah, N., Vaxillaire, M., Hansen, T. F., Tuomilehto, J., Gašperíková, D., Szopa, M., Tjora, E., James, T. J., Kokko, P., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2261-y · Cited by 119
Kuo, H.-K., Bean, J. F., Yen, C.-J., & Leveille, S. G. (2006) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/61.4.380 · Cited by 115
Vance, S. A., & Sandros, M. G. (2014) · Scientific Reports · doi:10.1038/srep05129 · Cited by 115
C-Reactive protein is inversely related to physical fitness in middle-aged subjects
Aronson, D., Sheikh‐Ahmad, M., Avizohar, O., Kerner, A., Sella, R., Bartha, P., Markiewicz, W., Levy, Y., & Brook, G. J. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.04.025 · Cited by 115
C-Reactive Protein Levels Are Not Associated with Increased Risk for Colorectal Cancer in Women
Zhang, S. M., Buring, J. E., Lee, I.-M. M., Cook, N. R., & Ridker, P. M. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-6-200503150-00008 · Cited by 115
Self-citationOwen, K. R., Thanabalasingham, G., James, T. J., Karpe, F., Farmer, A. A., McCarthy, M. I., & Gloyn, A. L. (2010) · Diabetes Care · doi:10.2337/dc10-0288 · Cited by 114
Gurbel, P. A., & Tantry, U. S. (2012) · Circulation · doi:10.1161/circulationaha.111.031195 · Cited by 115
Cardiovascular Morbidity and Mortality of the Metabolic Syndrome
Obunai, K., Jani, S., & Dangas, G. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2007.06.003 · Cited by 121
Assessment of Hemostatic Risk Factors in Predicting Arterial Thrombotic Events
Feinbloom, D. B., & Bauer, K. A. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000181762.31694.da · Cited by 112
Possible Protective Role for C-Reactive Protein in Atherogenesis
Bhakdi, S., Torzewski, M., Paprotka, K., Schmitt, S., Barsoom, H., Suriyaphol, P., Han, S., Lackner, K. J., & Husmann, M. (2004) · Circulation · doi:10.1161/01.cir.0000124228.08972.26 · Cited by 113
Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease
Sin, D. D., & Man, S. F. P. (2005) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y04-116 · Cited by 113
Indices of low-grade inflammation in polycystic ovary syndrome
DIAMANTI‐KANDARAKIS, E., PATERAKIS, T., & KANDARAKIS, H. A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.015 · Cited by 112
Adipose tissue, inflammation and cardiovascular disease
Ikeoka, D., Mader, J. K., & Pieber, T. R. (2010) · Revista da Associação Médica Brasileira · doi:10.1590/s0104-42302010000100026 · Cited by 110
Role of Depression and Inflammation in Incident Coronary Heart Disease Events
Shimbo, D., Chaplin, W. F., Crossman, D. J., Haas, D. C., & Davidson, K. W. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.05.064 · Cited by 110
C-Reactive Protein and All-Cause Mortality in a Large Hospital-Based Cohort
Marsik, C. L., Kazemi-Shirazi, L., Schickbauer, T., Winkler, S., Joukhadar, C., Wagner, O. F., & Endler, G. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.091959 · Cited by 111
Serum antibodies to periodontal pathogens and markers of systemic inflammation
Dye, B. A., Choudhary, K., Shea, S., & Papapanou, P. N. (2005) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2005.00856.x · Cited by 113
Heart Rate Characteristics Monitoring for Neonatal Sepsis
Moorman, J. R., Lake, D. E., & Griffin, M. P. (2005) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2005.859810 · Cited by 110
Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups
Joseph, J., Depp, C., Martin, A. S., Daly, R. E., Glorioso, D. K., Palmer, B. W., & Jeste, D. V. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.08.019 · Cited by 109
Iliodromitis, E. K., Kyrzopoulos, S., PARASKEVAIDIS, I. A., Kolocassides, K. G., Adamopoulos, S. N., Karavolias, G., & Kremastinos, D. T. (2006) · Heart · doi:10.1136/hrt.2006.089060 · Cited by 109
Role of High-Sensitivity C-reactive Protein (Hs-CRP) in Non-communicable Diseases: A Review
Banait, T., Wanjari, A., Danade, V., Banait, S., & Jain, J. (2022) · Cureus · doi:10.7759/cureus.30225 · Cited by 137
Park, D., Yun, S., Lee, J., Kim, W., Kang, S., Lee, S., Kim, Y., Lee, C. W., Kim, J., Park, S., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.876763 · Cited by 109
Plant, D. T., Pawlby, S., Sharp, D., Zunszain, P. A., & Pariante, C. M. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.155 · Cited by 108
C-reactive protein and risk of cardiovascular disease: Evidence and clinical application
Ridker, P. M., Bassuk, S. S., & Toth, P. P. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0004-3 · Cited by 108
Self-citationGender, Obesity and Repeated Elevation of C-Reactive Protein: Data from the CARDIA Cohort
Ishii, S., Karlamangla, A. S., Bote, M., Irwin, M. R., Jacobs, D. R., Cho, H. J., & Seeman, T. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036062 · Cited by 107
Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease
Osman, R., L’Allier, P. L., Elgharib, N. Z., & Tardif, J. (2006) · Vascular Health and Risk Management · doi:10.2147/vhrm.2006.2.3.221 · Cited by 111
Quantifying your body: A how‐to guide from a systems biology perspective
Smarr, L. L. (2012) · Biotechnology Journal · doi:10.1002/biot.201100495 · Cited by 111
Metadata
- Authors
- Ridker, P. M.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Ridker, Paul M
- ORCID
- Ridker, Paul M
- Venue
- Circulation
- Published
- 2003-01-28
- Volume
- 107
- Issue
- 3
- Pages
- 363-369
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2128722360
- Cited by
- 2,513
- References
- 44
- Citations by year
- 2026: 56 · 2025: 70 · 2024: 72 · 2023: 66 · 2022: 75 · 2021: 82 · 2020: 91 · 2019: 98 · 2018: 100 · 2017: 98 · 2016: 110 · 2015: 134 · 2014: 117 · 2013: 126 · 2012: 125
- FWCI
- 32.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01hl043851-10)
- U.S. Public Health Service (L58755)
- National Heart, Lung, and Blood Institute (HL43851, HL 63293, R01HL063293)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Immunology and Microbiology › Immunology › Biomarkers in Disease Mechanisms
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- C-reactive protein, cardiovascular disease, cardiovascular risk prediction, inflammatory markers, atherosclerosis, cardiovascular disease prevention
- MeSH terms
- C-Reactive Protein, Cardiovascular Diseases, Cost-Benefit Analysis, Demography, Diabetes Mellitus, Type 2, Goals, Humans, Mass Screening, Risk Factors, Biomarkers, Practice Guidelines as Topic, Disease-Free Survival, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review